These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 4196346)

  • 21. Acute and chronic effects of sulfonylurea drugs on pancreatic islet function in man.
    Pfeifer MA; Halter JB; Judzewitsch RG; Beard JC; Best JD; Ward WK; Porte D
    Diabetes Care; 1984; 7 Suppl 1():25-34. PubMed ID: 6376026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Current pathophysiological and clinical aspects of the mode of action of blood glucose lowering sulfonamides].
    Pfeiffer EF
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():477-502. PubMed ID: 4906024
    [No Abstract]   [Full Text] [Related]  

  • 23. The pharmacology and metabolism of oral antidiabetic drugs.
    Bänder A
    Aust N Z J Med; 1971 Aug; 1():Suppl 2:22-30. PubMed ID: 5005129
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical efficacy of glimepiride].
    Kaneko T; Sakamoto N
    Nihon Rinsho; 1997 Nov; 55 Suppl():152-7. PubMed ID: 9434460
    [No Abstract]   [Full Text] [Related]  

  • 25. Extrapancreatic effects of sulfonylurea drugs.
    Kaku K; Inoue Y; Kaneko T
    Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S105-8. PubMed ID: 8529502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes mellitus--a disease of pancreatic and extrapancreatic origin.
    Cerasi E; Luft R
    Adv Metab Disord; 1974; 7(0):193-212. PubMed ID: 4606429
    [No Abstract]   [Full Text] [Related]  

  • 27. Obesity and diabetes mellitus.
    Pfeiffer EF; Laube H
    Adv Metab Disord; 1974; 7(0):243-55. PubMed ID: 4606857
    [No Abstract]   [Full Text] [Related]  

  • 28. Mechanism of insulin secretion and its modulation by sulfonylureas.
    Panten U
    Contrib Nephrol; 1989; 73():16-21; discussion 22-3. PubMed ID: 2689091
    [No Abstract]   [Full Text] [Related]  

  • 29. [Physiological and pharmacological aspects of the central role of the pancreas in the mode of action of hypoglycemic sulfonamides].
    Loubatières A
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():216-55. PubMed ID: 4906020
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hypoglycemic sulfonamides].
    Loubatières AL
    Actual Pharmacol (Paris); 1968; 21():173-90. PubMed ID: 4888764
    [No Abstract]   [Full Text] [Related]  

  • 31. [Molecular mechanism of action of sulfonylureas].
    Ammon HP
    Dtsch Med Wochenschr; 1988 May; 113(21):864-70. PubMed ID: 3286184
    [No Abstract]   [Full Text] [Related]  

  • 32. [The present status of the question of the mechanism of action of sulfanilamide hypoglycemic preparations and several aspects of their use in the treatment of diabetes mellitus].
    Mordkovskaia NM
    Probl Endokrinol (Mosk); 1971; 17(5):121-5. PubMed ID: 4337075
    [No Abstract]   [Full Text] [Related]  

  • 33. [Primary and secondary failure of sulphonylureas].
    Kanno H; Sakura H
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():719-23. PubMed ID: 12430308
    [No Abstract]   [Full Text] [Related]  

  • 34. [Structure and action mechanism of sulfonylurea].
    Tasaka Y
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():333-8. PubMed ID: 12387014
    [No Abstract]   [Full Text] [Related]  

  • 35. Pancreatic action of the sulfonylureas.
    Grodsky GM; Epstein GH; Fanska R; Karam JH
    Fed Proc; 1977 Dec; 36(13):2714-9. PubMed ID: 200493
    [No Abstract]   [Full Text] [Related]  

  • 36. The pathogenesis of non-insulin-dependent diabetes: an update.
    DeFronzo RA; Ferrannini E
    Medicine (Baltimore); 1982 May; 61(3):125-40. PubMed ID: 7043155
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pathophysiology of diabetes mellitus type 2 and the mechanism of action and indications for using hypoglycemic sulfonylurea derivatives].
    Tatoń J; Koliński P
    Pol Tyg Lek; 1985 May; 40(18):505-11. PubMed ID: 3892513
    [No Abstract]   [Full Text] [Related]  

  • 38. An appraisal of the mechanism of action of the sulphonylurea drugs.
    Martin FI
    Aust N Z J Med; 1971 Aug; 1():Suppl 2:31-6. PubMed ID: 4949233
    [No Abstract]   [Full Text] [Related]  

  • 39. Salicylates as hypoglycemic agents.
    Baron SH
    Diabetes Care; 1982; 5(1):64-71. PubMed ID: 6754304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel sulfonylurea and non-sulfonylurea drugs to promote the secretion of insulin.
    Perfetti R; Ahmad A
    Trends Endocrinol Metab; 2000 Aug; 11(6):218-23. PubMed ID: 10878751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.